180 Life Sciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $166 | $166 |
Gross Profit | -23 | -23 | 143 |
EBITDA | -1,822 | -1,029 | -1,429 |
EBIT | -1,846 | -1,053 | -1,452 |
Net Income | 11 | -1,069 | -1,227 |
Net Change In Cash | 0 | 166 | 166 |
Free Cash Flow | 727 | -1,033 | -2,160 |
Cash | 1,146 | 675 | 1,975 |
Basic Shares | 919 | 638 | 622 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -105 | -109 | -116 | |
EBITDA | -22,134 | -17,788 | -9,692 | -5,258 |
EBIT | -22,239 | -17,897 | -9,817 | -5,383 |
Net Income | -19,935 | -38,726 | -10,884 | -10,884 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,922 | -12,127 | -3,871 | -3,871 |
Cash | 1,975 | 6,970 | 8,224 | 2,108 |
Basic Shares | 379 | 100 | 82 | 18,154 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.85 |
2024-06-30 | $0.01 |
2024-03-31 | -$1.67 |
2023-12-31 | -$26.60 |
